Coverage
-
September 20, 2021
A New Jersey federal judge on Monday found that Sandoz and Zydus Pharmaceuticals infringed several of Amgen's patents for its blockbuster plaque psoriasis medication Otezla, entering judgment in favor of Amgen on a trio of patents.
1 other articles on this case.
View all »